NCT00047034View on ClinicalTrials.gov

E7389 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

October 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

eribulin mesylate

Given IV

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00047034 - E7389 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter